Moshe Arkin 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-10 11:21 am Purchase | 2021-04-29 | 13D | Werewolf Therapeutics, Inc. HOWL | Moshe Arkin | 2,046,634 7.400% | 2,046,634 (New Position) | Filing |